Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.

Summary

Pancreatic, gastric, and colorectal cancers have all been shown to overexpress the gastrin gene and to be sensitive to the trophic effects of the gastrin in animal models. The hypothesis of this study is that G17DT will elicit specific and high-affinity antibodies that will bind gastrin-17, thus preventing the trophic activity of cancer cells.

Timeline

Start

1993-10

Primary completion

1994-05

Completion

1994-05

Drugs

Indications